Bonito Biosciences Overview
- Year Founded
-
2022
- Status
-
Private
- Employees
-
26
- Latest Deal Type
-
Series A
- Latest Deal Amount
-
$17M
- Investors
-
4
Bonito Biosciences General Information
Description
Developer of a targeted delivery platform designed to enable precise delivery of therapeutic payloads to defined cell and tissue types. The company offers small molecule and antibody discovery engines that create ligand-based delivery constructs, enabling biopharmaceutical developers to pursue RNA interference therapeutics, oncology applications, and small molecule drug discovery with high tissue specificity.
Contact Information
Website
www.bonitobio.comCorporate Office
- 852 Winter Street
- Waltham, MA 02451
- United States
Corporate Office
- 852 Winter Street
- Waltham, MA 02451
- United States
Bonito Biosciences Timeline
Bonito Biosciences Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 2. Early Stage VC (Series A) | 31-Oct-2025 | $17M | Completed | Generating Revenue | ||
| 1. Seed Round | 01-Dec-2024 | Completed | Generating Revenue |
Bonito Biosciences Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series A-3 | ||||||||
| Series A-2 | ||||||||
| Series A-1 | ||||||||
| Seed-2 | 2,673,879 | $0.000100 | 6% | $1.31 | $1.31 | 1x | $1.31 | 9.1% |
| Seed-1 | 5,484,792 | $0.000100 | 6% | $1.64 | $1.64 | 1x | $1.64 | 18.65% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Opportunity Score
Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.
Exit Type
Evaluates the likelihood of a successful exit for investors, and the most likely exit type.
Bonito Biosciences Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Bonito Biosciences Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Bonito Biosciences Investors (4)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Lightstone | Corporation | Minority | ||
| Anterra Capital | Venture Capital | Minority | ||
| JAZZ Venture Partners | Venture Capital | Minority | ||
| Lightstone Ventures | Venture Capital | Minority |
Bonito Biosciences FAQs
-
When was Bonito Biosciences founded?
Bonito Biosciences was founded in 2022.
-
Where is Bonito Biosciences headquartered?
Bonito Biosciences is headquartered in Waltham, MA.
-
What is the size of Bonito Biosciences?
Bonito Biosciences has 26 total employees.
-
What industry is Bonito Biosciences in?
Bonito Biosciences’s primary industry is Biotechnology.
-
Is Bonito Biosciences a private or public company?
Bonito Biosciences is a Private company.
-
What is the current valuation of Bonito Biosciences?
The current valuation of Bonito Biosciences is .
-
What is Bonito Biosciences’s current revenue?
The current revenue for Bonito Biosciences is .
-
How much funding has Bonito Biosciences raised over time?
Bonito Biosciences has raised $29.5M.
-
Who are Bonito Biosciences’s investors?
Lightstone, Anterra Capital, JAZZ Venture Partners, and Lightstone Ventures have invested in Bonito Biosciences.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
